Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 274

1.

Immune modulation by group B Streptococcus influences host susceptibility to urinary tract infection by uropathogenic Escherichia coli.

Kline KA, Schwartz DJ, Gilbert NM, Hultgren SJ, Lewis AL.

Infect Immun. 2012 Dec;80(12):4186-94. doi: 10.1128/IAI.00684-12. Epub 2012 Sep 17.

2.

Genome-wide mapping of cystitis due to Streptococcus agalactiae and Escherichia coli in mice identifies a unique bladder transcriptome that signifies pathogen-specific antimicrobial defense against urinary tract infection.

Tan CK, Carey AJ, Cui X, Webb RI, Ipe D, Crowley M, Cripps AW, Benjamin WH Jr, Ulett KB, Schembri MA, Ulett GC.

Infect Immun. 2012 Sep;80(9):3145-60. doi: 10.1128/IAI.00023-12. Epub 2012 Jun 25.

3.

Kinetics of uropathogenic Escherichia coli metapopulation movement during urinary tract infection.

Walters MS, Lane MC, Vigil PD, Smith SN, Walk ST, Mobley HL.

MBio. 2012 Feb 7;3(1). pii: e00303-11. doi: 10.1128/mBio.00303-11. Print 2012.

4.

Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages.

Bokil NJ, Totsika M, Carey AJ, Stacey KJ, Hancock V, Saunders BM, Ravasi T, Ulett GC, Schembri MA, Sweet MJ.

Immunobiology. 2011 Nov;216(11):1164-71. doi: 10.1016/j.imbio.2011.05.011. Epub 2011 May 24.

PMID:
21802164
5.

YbcL of uropathogenic Escherichia coli suppresses transepithelial neutrophil migration.

Lau ME, Loughman JA, Hunstad DA.

Infect Immun. 2012 Dec;80(12):4123-32. doi: 10.1128/IAI.00801-12. Epub 2012 Sep 10.

6.

Population dynamics and niche distribution of uropathogenic Escherichia coli during acute and chronic urinary tract infection.

Schwartz DJ, Chen SL, Hultgren SJ, Seed PC.

Infect Immun. 2011 Oct;79(10):4250-9. doi: 10.1128/IAI.05339-11. Epub 2011 Aug 1.

8.

Immune activation and suppression by group B streptococcus in a murine model of urinary tract infection.

Kline KA, Schwartz DJ, Lewis WG, Hultgren SJ, Lewis AL.

Infect Immun. 2011 Sep;79(9):3588-95. doi: 10.1128/IAI.00122-11. Epub 2011 Jun 20.

9.

Immunization with the yersiniabactin receptor, FyuA, protects against pyelonephritis in a murine model of urinary tract infection.

Brumbaugh AR, Smith SN, Mobley HL.

Infect Immun. 2013 Sep;81(9):3309-16. doi: 10.1128/IAI.00470-13. Epub 2013 Jun 24.

10.

Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract.

Lane MC, Alteri CJ, Smith SN, Mobley HL.

Proc Natl Acad Sci U S A. 2007 Oct 16;104(42):16669-74. Epub 2007 Oct 9.

11.

Uropathogenic Escherichia coli virulence and innate immune responses during urinary tract infection.

Ulett GC, Totsika M, Schaale K, Carey AJ, Sweet MJ, Schembri MA.

Curr Opin Microbiol. 2013 Feb;16(1):100-7. doi: 10.1016/j.mib.2013.01.005. Epub 2013 Feb 8. Review.

PMID:
23403118
12.
13.

Impact of host age and parity on susceptibility to severe urinary tract infection in a murine model.

Kline KA, Schwartz DJ, Gilbert NM, Lewis AL.

PLoS One. 2014 May 16;9(5):e97798. doi: 10.1371/journal.pone.0097798. eCollection 2014.

14.

Identification of in vivo-induced antigens including an RTX family exoprotein required for uropathogenic Escherichia coli virulence.

Vigil PD, Alteri CJ, Mobley HL.

Infect Immun. 2011 Jun;79(6):2335-44. doi: 10.1128/IAI.00110-11. Epub 2011 Mar 21.

15.

Dysregulation of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infection.

Nagamatsu K, Hannan TJ, Guest RL, Kostakioti M, Hadjifrangiskou M, Binkley J, Dodson K, Raivio TL, Hultgren SJ.

Proc Natl Acad Sci U S A. 2015 Feb 24;112(8):E871-80. doi: 10.1073/pnas.1500374112. Epub 2015 Feb 9.

16.

Virulence factors of uropathogenic E. coli and their interaction with the host.

Lüthje P, Brauner A.

Adv Microb Physiol. 2014;65:337-72. doi: 10.1016/bs.ampbs.2014.08.006. Epub 2014 Nov 4. Review.

PMID:
25476769
17.

The repeat-in-toxin family member TosA mediates adherence of uropathogenic Escherichia coli and survival during bacteremia.

Vigil PD, Wiles TJ, Engstrom MD, Prasov L, Mulvey MA, Mobley HL.

Infect Immun. 2012 Feb;80(2):493-505. doi: 10.1128/IAI.05713-11. Epub 2011 Nov 14.

18.

Distinguishing the contribution of type 1 pili from that of other QseB-misregulated factors when QseC is absent during urinary tract infection.

Kostakioti M, Hadjifrangiskou M, Cusumano CK, Hannan TJ, Janetka JW, Hultgren SJ.

Infect Immun. 2012 Aug;80(8):2826-34. doi: 10.1128/IAI.00283-12. Epub 2012 Jun 4.

19.

Modulation of host innate immune response in the bladder by uropathogenic Escherichia coli.

Billips BK, Forrestal SG, Rycyk MT, Johnson JR, Klumpp DJ, Schaeffer AJ.

Infect Immun. 2007 Nov;75(11):5353-60. Epub 2007 Aug 27.

20.

Urinary tract infections in renal transplant recipients: virulence traits of uropathogenic Escherichia coli.

Merçon M, Regua-Mangia AH, Teixeira LM, Irino K, Tuboi SH, Goncalves RT, Santoro-Lopes G.

Transplant Proc. 2010 Mar;42(2):483-5. doi: 10.1016/j.transproceed.2010.01.049.

PMID:
20304171
Items per page

Supplemental Content

Write to the Help Desk